Human Papillomavirus and Cellular Pathways: Hits and Targets
- PMID: 33668730
- PMCID: PMC7996217
- DOI: 10.3390/pathogens10030262
Human Papillomavirus and Cellular Pathways: Hits and Targets
Abstract
The Human Papillomavirus (HPV) is the causative agent of different kinds of tumors, including cervical cancers, non-melanoma skin cancers, anogenital cancers, and head and neck cancers. Despite the vaccination campaigns implemented over the last decades, we are far from eradicating HPV-driven malignancies. Moreover, the lack of targeted therapies to tackle HPV-related tumors exacerbates this problem. Biomarkers for early detection of the pathology and more tailored therapeutic approaches are needed, and a complete understanding of HPV-driven tumorigenesis is essential to reach this goal. In this review, we overview the molecular pathways implicated in HPV infection and carcinogenesis, emphasizing the potential targets for new therapeutic strategies as well as new biomarkers.
Keywords: AP-1; DNA damage response; EGFR; EMT; HPV; JAK/STAT; PI3K/Akt/mTOR; autophagy; cervical cancer; head and neck cancer; miRNA.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Giuliano A.R., Nyitray A.G., Kreimer A.R., Pierce Campbell C.M., Goodman M.T., Sudenga S.L., Monsonego J., Franceschi S. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int. J. Cancer. 2015;136:2752–2760. doi: 10.1002/ijc.29082. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
